Phenomics Australia awarded over $15m under the 2023 Research Infrastructure Investment Plan funding

Share this:

The Commonwealth Government Department of Education has announced that Phenomics Australia will receive over $15m under the National Collaborative Research Infrastructure Strategy (NCRIS), to address Australia’s strategic science and research priorities, driving the discovery of the molecular basis of disease to benefit the health of all Australians.

The funding is in addition to over $27m secured under the 2022 Research Infrastructure Investment Plan taking the total sum to over $42m for the period of 2023-2028.

The funding secures Phenomics Australia’s operations for the next 5 years, supporting the establishment of a new Synthetic Biology capability, along with the expansion of our continuing activities in Biobanking, In Vivo and In Vitro Genome Engineering and Disease Modelling, Functional Genomics and High-throughput Screening and Pathology.

“This funding demonstrates the value of the cutting-edge research infrastructure services and expertise offered by Phenomics Australia’s nodes and partner institutions”, Phenomics Australia CEO, Prof Michael Dobbie said. “This will strengthen Phenomics Australia’s capability to engineer and curate new and sophisticated model systems and novel materials that speed discovery and boost translation in Precision Medicine and beyond.”

Prof Michael Dobbie
Phenomics Australia, CEO

The following Phenomics Australia activities have been included on this funding round:

In the pipeline!

New Synthetic Biology activity: Established Phenomics Australia bioengineering capability will be applied to design, build and test bespoke mammalian lines as cell products themselves, or for cell-derived products through amplification (antibodies, vaccines, recombinant proteins, stem cell/ gene therapies, tissue engineering products).


Click image to check current services

BiobankingThe expansion of Phenomics Australia’s existing national biobanking capabilities will accommodate significant new demand for the cryopreservation of genome-engineered cells and cell products produced through Phenomics Australia In Vitro Genome Engineering and Disease Modelling services.



Click image to check current services

In Vivo Genome Engineering and Disease ModellingPhenomics Australia provides a national capability to explore the human genome and the genetic basis of health and disease. The expansion of these engineering and production capabilities will meet the significant new demand for increasingly complex and sophisticated model production.


Click image to check current services

In Vitro Genome Engineering and Disease ModellingCell and organoid models are powerful and accessible tools for the health discovery and the development and testing of potential therapeutics. The expansion of this capability will better serve the rapidly growing research and industry demand.


Click image to check current services

Functional Genomics and High-throughput ScreeningThis capability will be enhanced to perform a greater range and number of genome-scale, cell-based CRISPR, RNAi and compound screens in both 2-D cell lines and 3-D cell lines, patient-derived cells and xenografts, and complex disease models using sophisticated liquid handling automation, high content cellular phenotyping, and reporter-based readouts.


Click image to check current services

PathologyPhenomics Australia enables the detailed description of the pathological changes in disease models to efficiently determine the biological consequences of their genome and to relate mutant and other disease phenotypes to human disease, the efficacy of potential therapeutics, and identify off-target effects. The expansion of this activity will enable the necessary growth of capabilities to accommodate significant ongoing demand for services, and particularly by industry for large-project support.



Phenomics Australia Feedback Form

Phenomics Australia (formerly the Australian Phenomics Network, APN) offers consolidated infrastructure and expertise supporting genomic medicine and biomedical research from discovery through into early clinical development and evaluation.

Phenomics Australia is a founding capability enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). We would love to hear from you!

Please feel free to provide any ideas or general comments you might have so that we can further improve how Phenomics Australia can support you.

Phenomics Australia PHENOMENA News Contribution

Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.

Information provided will be used to inform press releases, website stories, social media content and more. This form is being used to capture everything that is happening at Phenomics Australia, which can then be used as part of our outreach and communications.

Once you have completed the form, the Communications and Outreach Coordinator will then be in contact with you.


Make an Enquiry

_Get in touch to discuss how we can help with your research.